NEW ROCHELLE, NY — August 28, 2007
The Medical Letter is pleased to announce the release of Treatment Guidelines from The Medical Letter for Pocket PC and BlackBerry, powered by USBMIS.
"Treatment Guidelines from The Medical Letter provides reviews of drug classes for treatment of major indications." said Mark Abramowicz, MD, Editor of The Medical Letter. "The extensive market penetration and excellent reputation of USBMIS products will make this important information more accessible to the healthcare community."
USBMIS, a respected software developer for the medical industry, plans to release more Medical Letter content in the near future.
For more information about Treatment Guidelines from The Medical Letter Pocket PC and BlackBerry editions, please visit http://www.usbmis.com/mldt/.
About The Medical Letter
The Medical Letter Inc., a nonprofit organization founded in 1958, offers health care professionals objective, independent analyses of both prescription and over-the-counter drugs. In addition to its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, it also publishes handbooks and software on topics such as adverse drug interactions and antimicrobial therapy. The Medical Letter, Inc. is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information about The Medical Letter call (800) 211-2769 or visit their Web site at www.medicalletter.org.
CONTACT:
Joanne Valentino
Director of Marketing & Communications
The Medical Letter
914.235.0500 ext. 345
joanne@medicalletter.org